Reply letter to "Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal"

被引：1
|
作者：
Hadigal, Sanjay [1 ]
Colombo, Laura [2 ]
Cook, Joseph [3 ]
机构：
[1] Viatris, Dept Med Affairs, Bangalore, India
[2] Viatris, Dept Med Affairs, Monza, Italy
[3] Viatris, Dept Med Affairs, Canonsburg, PA USA
来源：
JOURNAL OF MEDICAL ECONOMICS | 2023年 / 26卷 / 01期
关键词：
D O I：
10.1080/13696998.2023.2237379
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：933 / 934
页数：2
相关论文
共 50 条
  • [31] The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
    Nagy, Lisa
    Heikkinen, Terho
    Sackeyfio, Alfred
    Pitman, Richard
    PHARMACOECONOMICS, 2016, 34 (09) : 939 - 951
  • [32] Cost effectiveness of quadrivalent influenza vaccines in the elderly population of Malaysia
    Syed Mohamed Aljunid
    Nur Syazana Mad Tahir
    Aniza Ismail
    Aznida Firzah Abdul Aziz
    Amirah Azzeri
    S. A. Zafirah
    Azimatun Noor Aizuddin
    Scientific Reports, 13
  • [33] Cost effectiveness of quadrivalent influenza vaccines in the elderly population of Malaysia
    Aljunid, Syed Mohamed
    Tahir, Nur Syazana Mad
    Ismail, Aniza
    Aziz, Aznida Firzah Abdul
    Azzeri, Amirah
    Zafirah, S. A.
    Aizuddin, Azimatun Noor
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [34] The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
    Lisa Nagy
    Terho Heikkinen
    Alfred Sackeyfio
    Richard Pitman
    PharmacoEconomics, 2016, 34 : 939 - 951
  • [35] Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
    de Boer, Pieter T.
    Crepey, Pascal
    Pitman, Richard J.
    Macabeo, Berengere
    Chit, Ayman
    Postma, Maarten J.
    VALUE IN HEALTH, 2016, 19 (08) : 964 - 975
  • [36] Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis
    You, Joyce H. S.
    Ming, Wai-Kit
    Chan, Paul K. S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (03) : 564 - 571
  • [37] QUADRIVALENT INFLUENZA VACCINE IN HONG KONG- A COST-EFFECTIVENESS ANALYSIS
    You, J.
    Ming, W.
    Chan, P.
    VALUE IN HEALTH, 2014, 17 (07) : A678 - A678
  • [38] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINE IN THE UNITED STATES
    De Boer, P. T.
    Pitman, R. J.
    Macabeo, B.
    Chit, A.
    Postma, M. J.
    Crepey, P.
    VALUE IN HEALTH, 2014, 17 (07) : A679 - A679
  • [39] Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK
    Meier, G.
    Gregg, M.
    Nautrup, B. Poulsen
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (09) : 746 - 761
  • [40] The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required
    Newall, Anthony T.
    Dehollain, Juan Pablo
    VACCINE, 2014, 32 (12) : 1323 - 1325
12345